Literature DB >> 11788647

Associations of glucose control with insulin sensitivity and pancreatic beta-cell responsiveness in newly presenting type 2 diabetes.

Ahmed I Albarrak1, Stephen D Luzio, Ludovic J Chassin, Rebecca A Playle, David R Owens, Roman Hovorka.   

Abstract

We examined the ability of indices of insulin sensitivity and pancreatic beta-cell responsiveness to explain interindividual variability of clinical measures of glucose control in newly presenting type 2 diabetes. Subjects with newly presenting type 2 diabetes (n = 65; 53 males and 12 females; age, 54 +/- 1 yr; body mass index, 30.5 +/- 0.7 kg/m(2); mean +/- SE) underwent an insulin-modified iv glucose tolerance test to determine minimal model-derived insulin sensitivity (S(I)), glucose effectiveness, first-phase insulin secretion, and disposition index. Subjects also underwent a standard meal tolerance test (MTT) to measure fasting/basal (M(0)) and postprandial (M(I)) pancreatic beta-cell responsiveness. Stepwise linear regression used these indices to explain interindividual variability of fasting and postprandial plasma glucose and insulin concentrations and glycated hemoglobin (HbA(1C)). All measures of pancreatic beta-cell responsiveness (M(0), M(I), and first-phase insulin secretion) were negatively correlated with fasting plasma glucose (P < 0.01) and positively correlated with fasting plasma insulin (FPI) and insulin responses to MTT (P < 0.05). S(I) demonstrated negative correlation with FPI (P < 0.001) but failed to correlate with any glucose variable. M(I) followed by disposition index (composite index of insulin sensitivity and pancreatic beta-cell responsiveness) were most informative in explaining interindividual variability. It was possible to explain 70-80% interindividual variability of fasting plasma glucose, FPI, HbA(1C), and insulin responses to MTT, and only 25-40% interindividual variability of postprandial glucose. In conclusion, postprandial insulin deficiency is the most powerful explanatory factor of deteriorating glucose control in newly presenting type 2 diabetes. Indices of insulin sensitivity and pancreatic beta-cell responsiveness explain fasting glucose and HbA(1C) well but fail to explain postprandial glucose.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788647     DOI: 10.1210/jcem.87.1.8152

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Postprandial insulin and triglycerides after different breakfast meal challenges: use of finger stick capillary dried blood spots to study postprandial dysmetabolism.

Authors:  Sonia Kapur; Margaret N Groves; David T Zava; Sanjay Kapur
Journal:  J Diabetes Sci Technol       Date:  2010-03-01

2.  Improvement of beta-cell function in conjunction with glycemic control after medical nutrition therapy in newly-diagnosed type 2 diabetes mellitus.

Authors:  Mitsuyoshi Takahara; Toshihiko Shiraiwa; Yoshifumi Maeno; Kaoru Yamamoto; Yuka Shiraiwa; Yoko Yoshida; Norio Nishioka; Naoto Katakami; Iichiro Shimomura
Journal:  BMC Endocr Disord       Date:  2022-06-04       Impact factor: 3.263

3.  Beta cell response to a mixed meal in nigerian patients with type 2 diabetes.

Authors:  Ekenechukwu E Young; Sonny Chinenye; Chioma N Unachukwu
Journal:  BMC Endocr Disord       Date:  2012-06-27       Impact factor: 2.763

4.  Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetes.

Authors:  G B Bolli; S Luzio; S Marzotti; F Porcellati; C Sert-Langeron; B Charbonnel; Y Zair; D R Owens
Journal:  Diabetes Obes Metab       Date:  2011-03       Impact factor: 6.577

5.  Postprandial C-peptide to glucose ratio as a predictor of β-cell function and its usefulness for staged management of type 2 diabetes.

Authors:  Eun Young Lee; Sena Hwang; Seo Hee Lee; Yong-Ho Lee; A Ra Choi; Youngki Lee; Byung-Wan Lee; Eun Seok Kang; Chul Woo Ahn; Bong Soo Cha; Hyun Chul Lee
Journal:  J Diabetes Investig       Date:  2014-02-12       Impact factor: 4.232

6.  Normal meal tolerance test is preferable to the glucagon stimulation test in patients with type 2 diabetes that are not in a hyperglycemic state: Comparison with the change of C-peptide immunoreactivity.

Authors:  Youhei Fujioka; Tsuyoshi Okura; Keisuke Sumi; Kazuhisa Matsumoto; Kyoko Shoji; Risa Nakamura; Kazuhiko Matsuzawa; Shoichiro Izawa; Masahiko Kato; Shinichi Taniguchi; Kazuhiro Yamamoto
Journal:  J Diabetes Investig       Date:  2017-06-19       Impact factor: 4.232

7.  Mixed-meal tolerance test to assess residual beta-cell secretion: Beyond the area-under-curve of plasma C-peptide concentration.

Authors:  Yue Ruan; Ruben H Willemsen; Malgorzata E Wilinska; Martin Tauschmann; David B Dunger; Roman Hovorka
Journal:  Pediatr Diabetes       Date:  2019-02-19       Impact factor: 4.866

8.  Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents.

Authors:  Klaus-Dieter Kohnert; Petra Augstein; Eckhard Zander; Peter Heinke; Karolina Peterson; Ernst-Joachim Freyse; Roman Hovorka; Eckhard Salzsieder
Journal:  Diabetes Care       Date:  2009-02-24       Impact factor: 19.112

9.  Post-meal β-cell function predicts the efficacy of glycemic control in patients with type 2 diabetes inadequately controlled by metformin monotherapy after addition of glibenclamide or acarbose.

Authors:  Po-Hsun Chen; Yi-Ting Tsai; Jun-Sing Wang; Shi-Dou Lin; Wen-Jane Lee; Shih-Li Su; I-Te Lee; Shih-Te Tu; Yao-Hsien Tseng; Wayne H-H Sheu; Shih-Yi Lin
Journal:  Diabetol Metab Syndr       Date:  2014-05-31       Impact factor: 3.320

10.  The pathophysiology of glucose intolerance in newly diagnosed, untreated T2DM.

Authors:  Gareth J Dunseath; Stephen D Luzio; Rajesh Peter; David R Owens
Journal:  Acta Diabetol       Date:  2021-09-24       Impact factor: 4.280

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.